NCT06335888View on ClinicalTrials.gov

A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis

PHASE2RecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

February 3, 2025

Primary Completion Date

May 31, 2029

Study Completion Date

May 31, 2029

Conditions
Giant Cell Arteritis
Interventions
DRUG

AzaFol

AzaFol-PET/CT imaging

DRUG

FDG

FDG-PET/CT imaging

Trial Locations (1)

3010

RECRUITING

Department of Rheumatology and Immunology, University Hospital Bern, Inselspital, Bern

All Listed Sponsors
collaborator

Paul Scherrer Institut, Center for Proton Therapy

OTHER

lead

Insel Gruppe AG, University Hospital Bern

OTHER